FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

More From CBS Philly

Getaway Guide To Senior Discounts
RMHC Telethon: Bidding For Good
DIY St. Patrick’s Day Party Guide

Listen Live